FDA panel confronting peptide controversy
STAT News · LC · trust 37/100
Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."
Read the original at STAT News →
Open in TruthVane →